The essential role of the Y chromosome in primary male sex determination is well established and the gene that triggers this process is termed the testis-determining factor (TDF). Studies of the TDF locus in man have been facilitated by the existence of two conditions, 46,XY complete gonadal dysgenesis (lack of testis differentiation in subjects with a male karyotype), and 46,XX maleness (development of testes in subjects with an apparently female karyotype). The TDF locus has been mapped to the distal region of the short arm of the Y chromosome. A candidate gene for TDF has been cloned from this locus by Goodfellow and co-workers, and has been called sex-determining region Y (SRY). Several lines of evidence indicate that SRY is indeed the TDF. The SRY gene is a member of a family of DNA binding proteins, termed the high mobility group (HMG). Recent studies show that HMG proteins may influence gene transcription by binding to sequence specific sites and by changing the conformation of DNA. Hence, it is likely that SRY triggers testis determination by binding to sequence specific DNA sites. However, the physiologic binding site(s) of SRY in the human genome and the mode of action of SRY are unknown. Our principal hypothesis is that the SRY gene product controls male sex determination by initiating activation of a cascade of genes.
The specific aims of this proposal are: 1) To identify specific SRY binding sites in the human genome; 2) to determine the influence of SRY on the conformation of DNA and on transcriptional activation; 3) To determine the influence of naturally occurring mutations in the SRY gene on the ability of SRY protein to interact with its specific binding sites. 4) To investigate further the genetic basis of 46,XY gonadal dysgenesis in additional subjects by investigating SRY mutations in affected individuals and by performing linkage analysis in kindreds with inherited forms of gonadal dysgenesis. These studies will provide new information and be the foundation for future studies to examine the complex interplay of the genes that are necessary for normal testis determination. They will also permit a better understanding of abnormal sex differentiation.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD028318-02
Application #
2201001
Study Section
Reproductive Biology Study Section (REB)
Project Start
1993-06-01
Project End
1996-05-31
Budget Start
1994-06-01
Budget End
1995-05-31
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Sher, E S; Migeon, C J; Berkovitz, G D (1998) Evaluation of boys with marked breast development at puberty. Clin Pediatr (Phila) 37:367-71
Sher, E S; Addelston, M B; Plotnick, L et al. (1998) Molecular investigation of two male subjects with short stature and a 45,X/46,X,ring(Y) karyotype. Horm Res 49:46-50
Fuqua, J S; McLaughlin, J; Perlman, E J et al. (1997) Analysis of the SRY gene in gonadal tissue of subjects with 46,XY gonadal dysgenesis. J Clin Endocrinol Metab 82:701-2
Kwok, C; Tyler-Smith, C; Mendonca, B B et al. (1996) Mutation analysis of the 2 kb 5' to SRY in XY females and XY intersex subjects. J Med Genet 33:465-8
Fuqua, J S; Sher, E S; Perlman, E J et al. (1996) Abnormal gonadal differentiation in two subjects with ambiguous genitalia, Mullerian structures, and normally developed testes: evidence for a defect in gonadal ridge development. Hum Genet 97:506-11
Fuqua, J S; Sher, E S; Fechner, P Y et al. (1996) Linkage analysis of a kindred with inherited 46,XY partial gonadal dysgenesis. J Clin Endocrinol Metab 81:4479-83
Turner, B; Fechner, P Y; Fuqua, J S et al. (1995) Combined Leydig cell and Sertoli cell dysfunction in 46,XX males lacking the sex determining region Y gene. Am J Med Genet 57:440-3
Marcantonio, S M; Fechner, P Y; Migeon, C J et al. (1994) Embryonic testicular regression sequence: a part of the clinical spectrum of 46,XY gonadal dysgenesis. Am J Med Genet 49:1-5